Novavax Inc (NASDAQ:NVAX)

5.65
BATS BZX Real-Time Price
As of 3:18pm ET
 -0.105 / -1.83%
Today’s Change
5.30
Today|||52-Week Range
18.55
-45.09%
Year-to-Date
Is Novavax Stock a Buy Now?
Dec 01 / MotleyFool.com - Paid Partner Content
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.75
Today’s open5.81
Day’s range5.63 - 6.05
Volume221,844
Average volume (3 months)8,839,771
Market cap$657.5M
Data as of 3:18pm ET, 12/05/2023

Growth & Valuation

Earnings growth (last year)+64.09%
Earnings growth (this year)+74.87%
Earnings growth (next 5 years)+45.10%
Revenue growth (last year)+72.89%
P/E ratioNM
Price/Sales0.41
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MLLCFMolecular Partners A...0.000.00%
KZRKezar Life Sciences ...-0.00-0.36%
AUTLAutolus Therapeutics...+0.13+3.33%
AVROAVROBIO Inc+0.04+3.41%
Data as of 3:19pm ET, 12/05/2023

Financials

Next reporting dateFebruary 27, 2024
EPS forecast (this quarter)$2.56
Annual revenue (last year)$2.0B
Annual profit (last year)-$657.9M
Net profit margin-33.20%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts